Skip to content
ChroniclesLive
  • HOME
  • WORLD
    • NEWS
  • BUSINESS
    • AUTOMOBILE
  • TECHNOLOGY
    • DIGITAL MARKETING
    • MOBILE & GADGETS
    • CRYPTO
  • TRENDING NOW
  • ART & CULTURE
    • LIFESTYLE
    • FASHION
  • HEALTH
  • EDUCATION
  • MORE
    • SPORTS
    • ENTERTAINMENT
    • POLITICS
    • TRAVEL

Zealand Pharma A/S

GLP-1s tested for uses beyond weight loss, diabetes

by Akin Smith
GLP-1s tested for uses beyond weight loss, diabetes

Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images Think a …

Read more

Eli Lilly, drugmakers show off weight loss drug data

by Akin Smith
Eli Lilly, drugmakers show off weight loss drug data

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Think a friend or colleague should …

Read more

Weight loss drug contender Zealand Pharma jumps 23% on trial results

by Walter Watson
Weight loss drug contender Zealand Pharma jumps 23% on trial results

Vials on the Wegovy line at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Friday, March 8, 2024.  Bloomberg | Bloomberg | Getty Images LONDON — Shares of …

Read more

U.S. jobs report, ECB commentary

by Walter Watson
U.S. jobs report, ECB commentary

Stock price information reflected on a window at the Euronext NV stock exchange in Paris, France, on Monday, March 13, 2023.  Nathan Laine | Bloomberg | Getty Images LONDON — …

Read more

Amgen could threaten Novo Nordisk, Eli Lilly weight loss drug dominance

by Akin Smith
Amgen could threaten Novo Nordisk, Eli Lilly weight loss drug dominance

The injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois. Scott Olson | Getty Images Novo Nordisk and Eli Lilly have …

Read more

First NASH liver disease drug is here, more coming

by Akin Smith
First NASH liver disease drug is here, more coming

3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign …

Read more

Viking stock doubled Tuesday. Here’s where the next moves in the obesity space could come from

by Walter Watson
Viking stock doubled Tuesday. Here’s where the next moves in the obesity space could come from

Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but given the vast and valuable market, rivals are still eager to join the race. Bank …

Read more

Liver disease is newest weight loss drug use

by Akin Smith
Liver disease is newest weight loss drug use

Image of a healthy liver not ravaged by fatty liver disease. BSIP | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign …

Read more

Novo Nordisk and Eli Lilly rival soars 30% after promising weight-loss drug results

by Walter Watson
Novo Nordisk and Eli Lilly rival soars 30% after promising weight-loss drug results

Vials move along a conveyor at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Monday, June 12, 2023. The success of Novo’s bestsellers Ozempic and Wegovy, drugs that …

Read more

Boehringer Ingelheim, Terns, Viking may join market

by Akin Smith
Boehringer Ingelheim, Terns, Viking may join market

Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity.  Michael Siluk …

Read more

Older posts
Page1 Page2 Next →

Recent Posts

  • Revolutionizing Business Growth in the UK with Cutting-Edge Technology
  • HBO Almost Cut the ‘Industry’ Season Finale’s Most Shocking Scene
  • Need A Passport ASAP? Here Are 4 Secrets To Getting It Fast.
  • Amazon Asks Its Employees to Use Cedric Instead of ChatGPT
  • Raps’ Boucher motivated as camp opens in hometown
  • ABOUT US
  • CONTACT US
  • PRIVACY POLICY
  • COOKIES POLICY
  • DISCLAIMER
  • TERMS OF USE
  • DMCA
©2025 ChroniclesLive